Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
NCT: NCT06337292 · RECRUITING
Brief Summary
This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing for their definitive wound management. The primary outcome will be a composite outcome to evaluate clinical status 3 months after randomization.
Frequently Asked Questions
What is Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures?
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures is a clinical trial registered under NCT06337292. Current status: RECRUITING.
What is the status of NCT06337292?
The current status of NCT06337292 (Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures) is: RECRUITING.
When did Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures start?
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures started on 2025-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.